When is PM's next earnings date?

Based on SEC filing cadence, Philip Morris International Inc (PM)'s next quarterly reporting window is estimated around Dec 30, 2026.

How much is PM stock expected to move on earnings?

Volatility modeling currently projects a ±5.5% event move for PM, spanning a range between $196.83 and $219.75.

Stock Ratings / Health Care / PM / earnings

BTI (67) DFTX (47) RGC (38) TRLV (56) ⌘ Pro Terminal →

Philip Morris International Inc (PM) Next Earnings Date & Expected ±5.5% Move

$208.29 -0.24% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $208.70

Philip Morris International Inc (PM) earns a Roarable Rating of A- (Buy) with 83/100 RQD Confidence. High-quality cash engine (67.1% gross margin, 45% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.

ROARABLE A- • BUY Cap $325.43B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on PM Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is PM stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-03, Philip Morris International Inc (NYSE: PM) is rated A- (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 83/100 at a spot price of $208.29 (-0.24% 1D, market cap $325.43B). Pillar breakdown: Fundamental Cash Engine 16/20, Institutional 13F & Options Flow 19/20, SEC Balance-Sheet Forensics 16/20, FRED Macro Regime Fit 17/20, and Executive Insider Alignment 15/20. Across 1015 tracked Health Care issuers, PM ranks #7 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does PM compare to BTI and DFTX in the Health Care sector?

▼

Within the Health Care sector (Medicinal Chemicals and Botanical Products), PM carries a Roarable A- (83/100 RQD), trailing P/E of 28.6x, gross margin of 67.1%, and ROIC of 45.3%. By comparison, BTI (British American Tobacco Industries p.l.c. ADR) holds a C+ grade (67/100 RQD, P/E 32.8x, ROIC 9.9%, cap $132.90B) and DFTX (Definium Therapeutics Inc.) posts a D grade (47/100 RQD, P/E N/A, ROIC -32.2%, cap $4.88B). Among the 5-stock peer group, PM leads on earnings multiple (28.6x) while PM leads on capital efficiency (45.3% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for PM?

▼

Per PM's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001413329), Philip Morris International Inc generated $40.65B in revenue (+7.3% YoY), $11.35B in net income, and $10.66B in free cash flow against $69.19B in total assets and $34.75B in total debt. Key quantitative strengths: Strong cash generator (67.1% gross margin)—profits are backed by real money, not accounting tricks. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $208.71 (+0.20%)🧬 Cannibal Buyback (-2.08% YoY Shares)⚙️ Cash Engine: 16/20 (B+) • 26.2% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 83/100 (A-) historically ranked in the Top 7% of excess returns over the next 90 days (+8.7% avg 90D alpha vs SPY • 72.2% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERBUY • A-

3-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw A- · Rk A-

Each axis scored 0–20

12M PRICE TARGET CONE+11.2% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for PM)Realized 20D OHLCV Swing Band: ±5.5%

Deterministic 5-Pillar Attribution (83/100 Composite)

🔍 WHY PM SCORES 83/100 (A-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Whale & Options Positioning+19/20 pts (23% of score)

20D Institutional Volume Accumulation (±5.5% realized swing band)

▲ #2 Bullish Driver: Macro Regime Fit+17/20 pts (20% of score)

FRED Regime × Technicals: 92% of 52W Range • RSI-14 at 64.3 (BULLISH MOMENTUM)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution15/20 pts (-5 pt drag)

Cannibal Buyback (-2.08% YoY Shares) & executive Form 4 sales trim 5 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade B+$205.58-3.9% Next Q

Q2 (-2Q)

Grade A-$197.46+2.6% Next Q

Q3 (-1Q)

Grade A-$202.64+2.8% Next Q

Current

Grade A-$208.29+8.7% Hist 90D α

Trajectory: B+ (75) → A- (83)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the PM Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 83/100 (A-) score, PM faces multiple-compression risk if 28.6x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Broader market pullbacks can still drag down strong stocks in the short run.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-2.08% YoY Shares) — any gross margin slip below 64.6% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($195.19) or 200D SMA ($182.44) invalidates the momentum regime and cuts Target Base ($231.72) toward Bear Floor ($170.80).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $PM• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “PM Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 83%NO 17%Trade / Inspect Odds →

NEXT EST. WINDOW: Dec 30, 2026 (~56 DAYS)

Historical OHLCV Volatility ±5.5% Swing Band

±$11.46 Expected Swing

MODEL EARNINGS SETUP GAUGE

PM Quantitative Pre-Earnings Setup: 83/100

Trailing EPS: $7.28 • YoY Revenue Growth: 7.3%

Model Bullish Setup (83/100)Model Risk Weight (17/100)

Derived deterministically from RQD cash-flow quality, SEC accrual safety, and institutional flow (not a community poll).

LOG YOUR PERSONAL PRE-EARNINGS STANCE (SAVED LOCALLY IN BROWSER):

Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence

Period	Filed	Revenue	Net Profit	Free Cash Flow	Gross Margin
FY 2025	2025-12-31	$40.65B	$11.35B	$10.66B	67.1%
FY 2024	2024-12-31	$37.88B	$7.06B	$10.77B	64.8%
FY 2023	2023-12-31	$35.17B	$7.81B	$7.62B	67.1%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Options & Swing Structure Desk

Whale Flow & Momentum Playbook: Evaluating PM & AI Leaders Without Chasing Tops

✓Institutional whale strikes & implied earnings move audit on PM
✓How disciplined traders manage risk using pre-published trigger & invalidation levels
✓Includes nightly RQD rating-change & forensic signal email alerts on tracked leaders

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

PM // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +23.11%▲ ASCENDING CHANNEL

2026-11-03O $208.5H $208.8L $208.3C $208.3VOL 4.59M

RES: $215.5SUP: $185.4SMA50: $195.2SMA200: $182.4

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

PM Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 PM Butterfly Map → + Track PM →

Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle

22.0%/yr Implied 5Y Growth

vs. +7.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on PM today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for PM. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for PM today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (PM)

Health Care Rank #7 of 1015 ⚔️ BTI vs PM Full Matrix →

1. Head-to-Head Health Care Peer Comparison (PM vs. BTI, DFTX, RGC, TRLV)

Industry: Medicinal Chemicals and Botanical Products (23 Tracked Issuers)

Across 1015 tracked Health Care securities in the Roarable RQD universe, Philip Morris International Inc (PM) ranks #7 by composite RQD confidence (83/100, grade A-) and #6 by equity capitalization ($325.43B). Within this direct 5-issuer industry benchmark cohort, PM leads on earnings valuation at 28.6x trailing P/E, while PM leads on capital efficiency and profitability with 45.3% ROIC and 67.1% gross margin. PM currently leads its immediate peer cohort in composite quantitative strength at 83/100 (A-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
PM ACTIVE Philip Morris International Inc	A-	83/100	28.6x	67.1%	45.3%	-0.24%	$325.43B	Benchmark Subject
BTI British American Tobacco Industries p.l.c. ADR	C+	67/100	32.8x	—	9.9%	+0.63%	$132.90B	/bti-vs-pm →
DFTX Definium Therapeutics Inc.	D	47/100	—	—	-32.2%	-10.62%	$4.88B	/dftx-vs-pm →
RGC Regencell Bioscience Holdings Limited	D-	38/100	—	—	—	-6.26%	$3.33B	/rgc-vs-pm →
TRLV Trulieve Cannabis Corp. Subordinate Voting Shares	D+	56/100	—	60.2%	12.8%	+7.98%	$1.98B	/trlv-vs-pm →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001413329 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Philip Morris International Inc (PM) reported GAAP revenue of $40.65B (+7.3% vs. FY2024 revenue of $37.88B , and +15.6% cumulative change since FY2023) , GAAP net income of $11.35B, operating cash flow of $12.23B, and free cash flow of $10.66B (-1.0% YoY). On the balance sheet, PM closed FY2025 with $69.19B in total assets against $34.75B in total debt (Altman Z-Score: 4.52, Piotroski F-Score: 8/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$40.65B	$11.35B	$12.23B	$10.66B	$69.19B	$34.75B
FY2024 (FY)	2024-12-31	$37.88B	$7.06B	$12.22B	$10.77B	$61.78B	$32.24B
FY2023 (FY)	2023-12-31	$35.17B	$7.81B	$9.20B	$7.62B	$178.74B	$41.82B

3. PM Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is PM stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does PM compare to BTI and DFTX in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for PM?

Where is PM trading relative to its 50-day, 200-day, and 52-week technical levels?

PM last traded at $208.29 (-0.24% on volume of 5,111,828 shares), positioning the stock +6.71% above its 50-day simple moving average ($195.19) and +14.17% above its 200-day simple moving average ($182.44). Across its 52-week range of $142.11 to $214.35, PM sits at the 91.6% percentile with a 14-day RSI of 64.3 (BULLISH MOMENTUM) and an implied next-earnings move of ±5.5% ($196.83 to $219.75).

Direct Sub-Reports: PM RQD Cockpit PM 12M Forecast PM Earnings & Move PM Dividends & DRIP PM Insiders & 13F PM Whale Options PM Profit Sankey PM News & Why

ROARABLE RATING BRIEF • RQD 83/100 (A-) ✓ SEC XBRL & RQD VERIFIED

PM — Philip Morris International Inc: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit

Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Philip Morris International Inc (PM) earns a live Roarable RQD composite score of 83/100, corresponding to a A- letter grade (Roarable Buy) at a spot price of $208.29 (-0.24% 1D, market capitalization $325.43B).

Fundamental Cash Engine (16/20): Anchored by return on invested capital (ROIC) of 45.3%, gross margin of 67.1%, operating margin of 36.6%, and free cash flow yield of 3.28%.
Whale 13F & Options Flow (19/20) + Insider Conviction (15/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
Macro Regime Fit (17/20) + Forensic Balance Sheet (16/20): Incorporates a 0.93x equity beta, Altman Z-Score of 4.52, Piotroski F-Score of 8/9, and Debt/Equity of 0.85x.

2. Business Model, Unit Margins & SEC Financial Trajectory

Philip Morris International Inc (PM) is a NYSE-listed issuer classified in the Health Care sector and the Medicinal Chemicals and Botanical Products industry. Recent news headlines reference smoke-free revenue and the Zyn product line, .

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Philip Morris International Inc (PM) reported $40.65B in annual revenue (up from $37.88B in FY2024, +7.3% YoY) and $11.35B in GAAP net income. Over the multi-year SEC filing window from FY2023 ($35.17B revenue, $7.81B net income) through FY2025, PM scaled operating cash flow to $12.23B and free cash flow to $10.66B, backed by $69.19B in total assets against $34.75B in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

🐂 Primary Bull Case (A- • RQD 83/100): Strong cash generator (67.1% gross margin)—profits are backed by real money, not accounting tricks. Big institutional funds and options desks are actively positioning on the bullish side. With Fundamental Cash Engine at 16/20 and Institutional Whale Flow at 19/20, sustained execution supports upside toward the upper end of the $142.11 – $214.35 52-week range.
🐻 Primary Bear Case & Valuation Risk: Broader market pullbacks can still drag down strong stocks in the short run. Investors must weigh 28.6x trailing P/E and 21.7x EV/EBITDA against 36.6% operating margins and a 0.93x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Operating in Medicinal Chemicals and Botanical Products (Health Care), PM carries a macro regime beta of 0.93 and gross margin of 67.1%.

Key Question #1: Can PM sustain or expand its 36.6% operating margin and 45.3% ROIC against Medicinal Chemicals and Botanical Products peers over the next 4 quarters?
Key Question #2: Following FY2025 revenue of $40.65B and free cash flow of $10.66B, how will capital allocation balance growth reinvestment against $34.75B in total debt?
Key Question #3: How sensitive is PM's 26.6x forward P/E multiple to Health Care capital spending cycles and macro interest-rate shifts (Beta 0.93x)?

PM Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Philip Morris International Inc (PM) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to PM Debate Forum (3) ↓

🟡 MARKET WIRE Yahoo Finance • 23h ago

Philip Morris (PM) Passed 40% Smoke-Free Revenue, but Cigarettes Did the Growing

Yahoo Finance report covering Philip Morris International Inc (PM) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Trefis • 1d ago

Philip Morris International Stock: 5 Straight Green Days, Up 7.5%

Trefis report covering Philip Morris International Inc (PM) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE WSJ • 1d ago

Philip Morris Doubles Down on Zyn, Despite Mounting Cost Pressures

WSJ report covering Philip Morris International Inc (PM) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔴 RISK WATCH Reuters • 1d ago

Philip Morris warns conflicts are raising costs, hurting earnings

Reuters report covering Philip Morris International Inc (PM) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST Seeking Alpha • 1d ago

Philip Morris: Strong Growth, 9% Dividend Growth, And More Upside Potential

Seeking Alpha report covering Philip Morris International Inc (PM) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST 24/7 Wall St. • 1d ago

Philip Morris Just Raised Its Dividend 8.8%. Can It Afford Another Increase?

24/7 Wall St. report covering Philip Morris International Inc (PM) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE TradingKey • 1d ago

Philip Morris International Inc Stock (PM) Moved Up by 3.73% on Oct 8: A Full Analysis

TradingKey report covering Philip Morris International Inc (PM) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 1d ago

Philip Morris (PM) Stock Looks Richly Valued After $16b Smoke Free Push

Yahoo Finance report covering Philip Morris International Inc (PM) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

PM Bull vs. Bear Conversation Board — What's Your Call at $208.29?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON PM 🐻 33% BEARISH CONVICTION

SI SiliconVal_Bull RQD DEBATE OPENER • Growth & Tech Investor 🐂 BULLISH 🎯 Target: $273.51 (+31.0%)

📌 Pinned Debate

Per the RQD rating, the Whale 13F Flow pillar scores 18 / 20 alongside ROIC of 45.3%, indicating strong institutional interest and capi

Don't sleep on PM's setup in Health Care. Per the RQD rating, the Whale 13F Flow pillar scores 18 / 20 alongside ROIC of 45.3%, indicating strong institutional interest and capital efficiency.. Beta of 0.93 means it moves fast when momentum turns, and the 5-pillar RQD gauge (83/100) backs up the fundamental quality.

SectorRotator 🐂 BULL

@SiliconVal_Bull Agree on the RQD 83/100 quality, though with 0.93 beta I'm scaling in with half-size at $208.79 and keeping dry powder in case we test $194.17.

CR CreditSpread_Watch RQD DEBATE OPENER • Balance Sheet Analyst 🐻 BEARISH 🎯 Target: $164.94 (-21.0%)

Spot @ $208.79

Per the Recent News section, a Reuters headline flags that conflicts are raising costs and hurting earnings, with P/E (TTM) of 28.6 lea

Here is the bear case nobody on the bull side wants to address on PM: Per the Recent News section, a Reuters headline flags that conflicts are raising costs and hurting earnings, with P/E (TTM) of 28.6 leaving limited valuation cushion.. At 28.6x trailing P/E, even a small guidance miss in Medicinal Chemicals and Botanical Products triggers a 12-15% air pocket.